A Phase III Trial of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer Previously Treated With or Resistant to an Anthracycline and Who Are Taxane Resistant.
Phase of Trial: Phase III
Latest Information Update: 24 Aug 2016
At a glance
- Drugs Vinflunine (Primary) ; Capecitabine
- Indications Advanced breast cancer
- Focus Registrational; Therapeutic Use
- Sponsors Pierre Fabre
- 12 Oct 2014 According to UKCRN record, planned number of patients reported as 764.
- 11 Jun 2014 Planned End Date changed from 1 Apr 2013 to 1 Jun 2014 as reported by ClinicalTrials.gov record.
- 03 Jun 2014 Primary endpoint 'Progression-free-survival' has been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History